The division of MS in "types" was made up just to approve interferons
The division of MS in "types" was made up just to approve interferons
https://onlinelibrary.wiley.com/doi/ful ... /ene.13819
There has been a reduction in the proportion of people with PPMS. This is probably related to the fact that there are no licensed treatments for PPMS; patients may be labelled as having relapsing MS in order to receive treatment, raising ethical questions about the division of MS into distinct subtypes. This artificial division of MS into different diseases was driven by the pharmaceutical industry to get interferon beta licensed under the Orphan Drug Act in the USA.
Here there is a longer explanation:
https://multiple-sclerosis-research.org ... -kool-aid/
The construct that MS has distinct phases, an early inflammatory and a delayed degenerative phase, is artificial and comes from the Pharma industry’s need to get interferon-beta licensed under the orphan drug act, i.e. MS had to have a prevalence of fewer than 200,000 affected people for the orphan drug act to apply. The only way to get the numbers down to less than 200,000 was to salami-slice up MS into three diseases, i.e. RRMS, SPMS and PPMS.
More reports against the classification in "types" here:
viewtopic.php?f=59&t=30871
viewtopic.php?f=59&t=31281
new "type" under research
https://journals.sagepub.com/doi/full/1 ... 8520925369
https://journals.sagepub.com/doi/full/1 ... 8520924595
Abstract
While the major phenotypes of multiple sclerosis (MS) and relapsing–remitting, primary and secondary progressive MS have been well characterized, a subgroup of patients with an active, aggressive disease course and rapid disability accumulation remains difficult to define and there is no consensus about their management and treatment.
The current lack of an accepted definition and treatment guidelines for aggressive MS triggered a 2018 focused workshop of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) on aggressive MS. The aim of the workshop was to discuss approaches on how to describe and define the disease phenotype and its treatments.
Unfortunately, it was not possible to come to consensus on a definition because of unavailable data correlating severe disease with imaging and molecular biomarkers. However, the workshop highlighted the need for future research needed to define this disease subtype while also focusing on its treatment and management.
Here, we review previous attempts to define aggressive MS and present characteristics that might, with additional research, eventually help characterize it. A companion paper summarizes data regarding treatment and management
-
- Similar Topics
- Replies
- Views
- Last post
-
-
MS review: The division of MS in "types" was made up just to approve interferons
by frodo » Mon Mar 04, 2019 3:15 am » in General Discussion - 4 Replies
- 878 Views
-
Last post by 1eye
Mon Apr 08, 2019 7:20 pm
-
-
-
Report against division of MS in clinical types
by frodo » Wed Apr 03, 2019 6:56 am » in MS Etiology and Pathogenesis - 0 Replies
- 536 Views
-
Last post by frodo
Wed Apr 03, 2019 6:56 am
-
-
- 0 Replies
- 606 Views
-
Last post by frodo
Wed Jan 08, 2020 6:39 am
-
-
MS clinical types are obsolete
by frodo » Sun Dec 08, 2019 4:57 am » in MS Etiology and Pathogenesis - 0 Replies
- 666 Views
-
Last post by frodo
Sun Dec 08, 2019 4:57 am
-
-
-
RNA signature of different lesion types in MS
by frodo » Tue Apr 30, 2019 4:34 am » in MS Etiology and Pathogenesis - 0 Replies
- 399 Views
-
Last post by frodo
Tue Apr 30, 2019 4:34 am
-
-
-
Two molecular types of lesions via MRI
by frodo » Mon Sep 14, 2020 1:34 am » in MS Etiology and Pathogenesis - 0 Replies
- 280 Views
-
Last post by frodo
Mon Sep 14, 2020 1:34 am
-
-
-
Automatic segmentation of different lesion types
by frodo » Tue Jun 23, 2020 8:44 am » in MS Etiology and Pathogenesis - 0 Replies
- 128 Views
-
Last post by frodo
Tue Jun 23, 2020 8:44 am
-
-
-
several types of alterations in NAWM and NAGM
by frodo » Sat Mar 23, 2019 4:25 am » in MS Etiology and Pathogenesis - 0 Replies
- 348 Views
-
Last post by frodo
Sat Mar 23, 2019 4:25 am
-
-
-
Correlation of clinical courses and pathophysiological types
by frodo » Wed Oct 09, 2019 11:40 am » in MS Etiology and Pathogenesis - 0 Replies
- 809 Views
-
Last post by frodo
Wed Oct 09, 2019 11:40 am
-